Research - Warsaw, Masovian Voivodeship, Poland
NanoSanguis is a company founded to bring to the market first safe and effective red blood cell substitute. The company has its origin in Warsaw University of Technology. We have started as a team of PhD candidates developing technology of oxygen therapeutics. In December 2015, together with two VC capitals – Start Venture Poland and Giza Polish Ventures, we created NanoSanguis to give synthetic blood every human in need regardless of their origin, social status and religious beliefs.
Outlook
Apache
WordPress.org
Mobile Friendly
Google Analytics